Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKβ inhibitors
- 15 June 2010
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (12), 3821-3825
- https://doi.org/10.1016/j.bmcl.2010.04.022
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinaseNature, 1999
- Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic CellsOnline Journal of Public Health Informatics, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesThe New England Journal of Medicine, 1997
- IκB proteins: structure, function and regulationSeminars in Cancer Biology, 1997
- NF-κB: Ten Years AfterCell, 1996
- Role of I Bα Ubiquitination in Signal-induced Activation of NF- B in VivoOnline Journal of Public Health Informatics, 1996
- Critical Role for Lysines 21 and 22 in Signal-induced, Ubiquitin-mediated Proteolysis of IkB-αOnline Journal of Public Health Informatics, 1996
- Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors.Proceedings of the National Academy of Sciences of the United States of America, 1994